Pembrolizumab plus chemoradiotherapy effective in locally advanced cervical cancer

被引：2
作者：
Sidaway, Peter
机构：
[1] Nature Reviews Clinical Oncology,
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2024年 / 21卷 / 06期
关键词：
D O I：
10.1038/s41571-024-00889-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：402 / 402
页数：1
相关论文
共 1 条
[1]   Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial [J].
Lorusso, Domenica ;
Xiang, Yang ;
Hasegawa, Kosei ;
Scambia, Giovanni ;
Leiva, Manuel ;
Ramos-Elias, Pier ;
Acevedo, Alejandro ;
Sukhin, Vladyslav ;
Cloven, Noelle ;
Gomes, Andrea J. Pereira de Santana ;
Mejia, Fernando Contreras ;
Reiss, Ari ;
Ayhan, Ali ;
Lee, Jung-Yun ;
Saevets, Valeriya ;
Zagouri, Flora ;
Gilbert, Lucy ;
Sehouli, Jalid ;
Tharavichitkul, Ekkasit ;
Lindemann, Kristina ;
Lazzari, Roberta ;
Chang, Chih-Long ;
Lampe, Rudolf ;
Zhu, Hong ;
Oaknin, Ana ;
Christiaens, Melissa ;
Polterauer, Stephan ;
Usami, Tomoka ;
Li, Kan ;
Yamada, Karin ;
Toker, Sarper ;
Keefe, Stephen M. ;
Pignata, Sandro ;
Duska, Linda R. .
LANCET, 2024, 403 (10434) :1341-1350
1